Key Financial Data Of Group

K Pharma,Inc. - Filing #7337586

Concept 2024-01-01 to
2024-03-31
As at
2024-03-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Key financial data of group
Business results of group
Net sales
JPY
1,000,000,000 JPY
Ordinary profit (loss)
-230,771,000 JPY
344,184,000 JPY
Net assets
2,871,319,000 JPY
3,104,768,000 JPY
Total assets
2,972,056,000 JPY
3,313,902,000 JPY
Basic earnings (loss) per share
-20.12
25.42
Diluted earnings per share
23.07
Equity-to-asset ratio
0.966 xbrli:pure
0.937 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.